Related Experiment Videos
Cancer after pre-eclampsia: follow up of the Jerusalem perinatal study cohort
Ora Paltiel1, Yehiel Friedlander, Efrat Tiram
1Braun School of Public Health and Community Medicine, Hadassah-Hebrew University, Jerusalem 91120, Israel. ora@vms.huji.ac.il
Objective:
To compare the incidence of cancer among women with and without a history of pre-eclampsia.
Design:
Cohort study.
Setting:
Jerusalem perinatal study of women who delivered in three large hospitals in West Jerusalem during 1964-76.
Participants:
37 033 women.
Main Outcome Measures:
Age adjusted and multivariable adjusted hazard ratios for cancer incidence for the entire cohort and for women who were primiparous at study entry.
Results:
Cancer developed in 91 women who had pre-eclampsia and 2204 who did not (hazard ratio 1.27, 95% confidence interval 1.03 to 1.57). The risk of site specific cancers was increased, particularly of the stomach, ovary epithelium, breast, and lung or larynx. The incidence of cancer of the stomach, breast, ovary, kidney, and lung or larynx was increased in primiparous women at study entry who had a history pre-eclampsia.
Conclusions:
A history of pre-eclampsia is associated with increases in overall risk of cancer and incidence at several sites. This may be explained by environmental and genetic factors common to the development of pre-eclampsia and cancer in this population.
Related Concept Videos
Teratogenicity
Diabetes Mellitus: Type 2 and Gestational
Cancer Survival Analysis
Chronic Pancreatitis II: Collaborative Care
Assessment:
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Psychoneuroimmunology: Diabetes and Cancer